kidney cancer

Merck
Pharma

Welireg's RCC wins could pad Merck's post-Keytruda sales

The combination win with Merck's own Keytruda represented more of a definite victory, according to one group of analysts.
Merck Welireg

FDA signs off on Merck’s Welireg to treat adrenal system tumors

May 15, 2025 10:43am
Exelixis

Exelixis shifts focus as triplet misses OS mark in kidney cancer

Feb 18, 2025 1:30pm
Merck Welireg

Merck's Welireg again comes up short in OS but excels in PFS

Sep 13, 2024 8:00am
Fotivda

BMS' Opdivo, Aveo's Fotivda fail as combo in kidney cancer

Jul 18, 2024 4:26pm
Merck KGaA

ASCO: Merck KGaA's Bavencio combo misses survival mark in RCC

May 23, 2024 5:00pm